help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F.
Right arrow Articles by Demers, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F.
Right arrow Articles by Demers, L. M.
(American Journal of Pathology. 1999;155:275-284.)
© 1999 American Society for Investigative Pathology


Regular Articles

Nitric Oxide Inhibits HIV Tat-Induced NF-{kappa}B Activation

Fei Chen*, Yongju Lu*, Vince Castranova*, Yon Rojanasakul{dagger}, Kaoru Miyahara{ddagger}, Yutaka Shizuta{ddagger}, Val Vallyathan*, Xianglin Shi* and Laurence M. Demers§

From the Pathology and Physiology Research Branch,*
Health Effects Laboratory Division, National Institute for Occupational Safety and Health, and the Department of Basic Pharmaceutical Sciences,{dagger}
West Virginia University, Morgantown, West Virginia, the Department of Medical Chemistry,{ddagger}
Kochi Medical School, Kochi, Japan, and the Department of Pathology,§
The Pennsylvania State University College of Medicine, Hershey, Pennsylvania

To evaluate the roles of nitric oxide (NO) on human immunodeficiency virus (HIV) Tat-induced transactivation of HIV long terminal repeat (HIV-LTR), we examined the effect of NO in the regulation of nuclear factor (NF)-{kappa}B, a key transcription factor involved in HIV gene expression and viral replication. In the present study, we demonstrate that HIV Tat activates NF-{kappa}B and that this activation can be attenuated by endogenous or exogenous NO. Inhibition of endogenous NO production with the NO synthase (NOS) inhibitor L-NMMA causes a significant increase in Tat-induced NF-{kappa}B activity. In addition, NO attenuates signal-initiated degradation of I{kappa}B{alpha}, an intracellular inhibitor of NF-{kappa}B, and blocks the DNA binding activity of the NF-{kappa}B p50/p50 homodimer and p50/p65 heterodimer. To determine how NO is induced by HIV Tat, reverse transcription polymerase chain reaction was used to demonstrate the induction of NOS-2 and NOS-3 mRNA by Tat. Although a putative NF-{kappa}B binding site was identified in the -74 GGAGAGCCCCC -64 region of the NOS-3 gene promoter, gel mobility shift assays and site-directed mutation analyses suggest that the putative NF-{kappa}B site is not of primary importance. Rather, several Sp-1 sites adjoining the putative NF-{kappa}B binding site in the promoter region of NOS-3 gene are required for the induction of NOS-3 gene expression by Tat.





This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, C. L. Olds, J. D. Bub, and P. F. Lindholm
Transfection of human endothelial cells with HIV-1 tat gene activates NF-kappa B and enhances monocyte adhesion
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2315 - H2321.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Dickie, A. Roberts, and R. Lee
A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production
J. Leukoc. Biol., October 1, 2001; 70(4): 592 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Jiménez, J. González-Nicolás, S. Alvarez, M. Fresno, and M. A. Muñoz-Fernández
Regulation of Human Immunodeficiency Virus Type 1 Replication in Human T Lymphocytes by Nitric Oxide
J. Virol., May 15, 2001; 75(10): 4655 - 4663.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
U. Ponnappan and L. S. F. Soderberg
Inflammatory macrophage nuclear factor-{kappa}B and proteasome activity are inhibited following exposure to inhaled isobutyl nitrite
J. Leukoc. Biol., April 1, 2001; 69(4): 639 - 644.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.